INTRODUCTION
Hodgkin's lymphoma (HL) is one type of lymphoproliferative malignancy, mostly originating from of Bcells [1] . It is of great importance to differentiate Hodgkin's lymphoma (cHL) from of non-Hodgkin lymphoma (NHL) by applying immunopathological features and adopting histomorphology approaches. HL is also categorized into the classical Hodgkin's lymphoma (cHL) and nodular lymphocyte-predominant Hodgkin's 2 lymphoma (NLPHL) [2] [3] [4] . Classical HL is subcategorized into several sub-types such as nodular sclerosis (NS), mixed cellularity (MC), lymphocyte depletion (LD), and lymphocyte-rich (LR) Hodgkin's lymphoma [5] . The neoplastic cells in cHL are known as Hodgkin and Reed-Sternberg (HRS) and are derived from germinal center (GC) or post-GC B cells and undergo somatic hypermutations in variable genes of IGH [6] . However, immunophenotyping analyses have shown that HRS cells posses surface antigen receptors, copresented in the T cells, cytotoxic cells, B cells, dendritic cells, granulocytes, and activation marker [7] . Due to the scarcity of HRS cell population, failure of the surface antigen expression, and acquired somatic mutation, determination of cancerous cell lineage by immunophenotyping and molecular approaches is very difficult [8, 9] . Routinely, histomorphological features and immunohistochemistery assessments are the principle of diagnosis in HL, whereas the availability of BIOMED-2 protocols may increase our ability to improve diagnosis of such cases. Moreover, clonality assays of Ig gene rearrangement (IGH and IGH D-J) are valuable method for an accurate diagnosis of HL [10] . Molecular clonality analysis of Ig rearrangements have been suggested as an appropriate method for diagnosis of hemato-malignancies [11, 12] . To date, few investigations have attempted to reveal monoclonality rearrangements in HL cases [13] [14] [15] [16] . In the present study, we used the BIOMED-2 multiplex PCR protocol to evaluate the rate of positive gene rearrangement clonality in IGH and IGH D-J to improve diagnosis and increase sensitivity of pathological features of HL. In the PCR assessment, monoclonality was confirmed when one band in PCR product background was detected. Observation of more than four clonal rearrangements was considered as oligoclonality and multiple clonal rearrangements were considered as polyclonality.
MATERIALS AND METHODS

Sample preparation
In the present study, we analyzed 50 formalin-fixed, paraffin-embedded (FFPE) tissues, which had been reported as HL malignancies by using immunophenotyping and morphological assessments. All of the FFPE blocks were provided between 2010 and 2013. Definite diagnosis of HL was made as the inclusion criteria. The subjects whose specimens had no history of the other hematologic malignancies were studied, and all samples were re-evaluated by the pathological board on the bases of histological features and immunohistochemical (IHC) staining. All of the participants have given informed written consent and the study protocol was approved by the Ethics Committee of Tabriz University of Medial Sciences (TUMS) which was in compliance with the Helsinki Declaration.
DNA extraction
To analyse the molecular clonality, three sections of 10 µm FFPE samples were used for extraction of DNA according to the protocol previously described by Isola et al. [17] . For assessment of quality and quantity of extracted DNA, amplified BIOMED-2 control genes and UV spectrophotometry (260/280 nm using the NanoDropTM ND-1000, NanoDrop Technology, Wilmington, DE, USA) were used [10] . The mean DNA concentration was 400 ng/µL and OD260/280 ratio was 1.85. All the samples were confirmed according to the Euro/ Clonality BIOMED-2 guideline [18] .
Immunophenotyping assays
Immunohistochemical staining was carried out on 4 µm thick tissue sections using monoclonal antibodies against CD30 (clone Ber-H2; Dako) and CD20 (clone L26; Dako) for isolation of HRS cells and recognition of B cells. For isolation of monocytes and granulocytes, anti-CD15 (clone LeuM1; Becton-Dickinson) was utilized. Anti-CD45/LCA (leukocyte common antigen) (clone 2B11; Dako) was used for screening of hematopoietic origin cells and anti-facsin (clone 55K-2; Dako) for isolation of the HRS cells. Immunophenotyping was performed as described previously [15] .
Clonality analysis
We utilized a multiplex PCR protocol provided by the European Biomedicine and Health (BIOMED-2) Concerted Action Project BMH4-CT98-3936 for accurate diagnosis and analysis of clonal gene rearrangements in lymphoproliferative disorders. Subsequent to the IGH and IGH D-J gene amplification, PCR products were denatured for 5 minutes at 94°C and incubated for 60 minutes at 4°C. Afterwards, 10 µL of PCR products was loaded on non-denaturing polyacrylamide gel (8%) and stained with silver nitrate. In each electrophoresis run, lymphatic tissue (Tonsil) was utilized as a polyclonal DNA sample, sterile water as negative and the sensitivity panel IVS-0010 (5%) control clonal DNA (InvivoScribe; catalog No.: 4-088-0590) as a positive sample. Clonality analysis was performed using amplification on three frameworks (FRs) of IGH (V H FR1-J H , V H FR2-J H , and V H FR3-J H ) and two segments of IGH D-J (DH 1-6 -JH and DH 7 -JH) gene rearrangements using the multiplex PCR protocols suggested by BIOMED-2 (Table 1 ) [10] . To avoid pseudoclonality detection, all of the samples were analyzed in duplicate.
Statistical analysis
To determine significant levels between CD30, CD20, CD15, CD45, and Facsin marker expressed in cancerous cells and clonality rates, Pearson's chi-square (χ 2 test) and Fisher's exact tests (SPSS statistical software, version 19.0 (SPSS Inc., Chicago, IL, USA) were performed. P-values < 0.05 were considered statistically significant. (Table 2 ). There was a statistically significant difference between positive CD30, CD20, CD45, CD15, and Facsin markers expressed in cancerous cells and monoclo- 
DISCUSSION
The present study was designed to assess an auxiliary method to improve clinical diagnosis by means of the BIOMED-2 molecular gene rearrangements protocol in FFPE tissue of HL samples. Clonal gene rearrangements in IGH and IGH D-J genes in 50 FFPE cases, reported as several sub-types of HL involving NS, MC, LD, and NLPHL neoplasms, were investigated. We studied clonal gene rearrangements in FRI, FRII, and FRIII of complete IGH and incomplete IGH D-J genes. Our results indicated a total monoclonality of 86% (43/50). Monoclonality was identified in 37 out of 50 (74%) HL cases. With respect to the rate of clonal rearrangements in FRI-J H , no monoclonality was detected in any of the sub-types of HL. These findings are compatible with those of the previous investigations [9, 11, [13] [14] [15] . In the analysis of FRII-J H and FRIII-J H gene rearrangements, we demonstrated a positive clonality in 71% (31/43) and 86% (6/7) of cHL and NLPHL types, respectively. A positive clonality of 74% was identified in the present study, which was a significant improvement compared to other studies, which reported a clonality of 15.5%, 44.5%, 50%, 10%, and 24% [9, 11, [13] [14] [15] , respectively. We have also observed a monoclonality of 86% in the IGH assay within NLPHL cases, whereas other reports failed to show any positive clonality in this regard [15, 19] . Several factors such as histological structures, sample types, and specificity assessments have been suggested to affect the rate of the positive monoclonality rearrangements assay by means of BIOMED-2 protocols [10] . In order to enhance of the positive rate of detection of clonal gene rearrangements, we included additional Ig genes such as IGH D-J, which are less susceptible to somatic hypermethylation. A positive monoclonality rate of 28% and 14% were seen in DH [1] [2] [3] [4] [5] [6] -JH and DH 7 -JH gene rearrangements. Subsequent to assessment of IGH D-J clonal gene rearrangements, a positive clonality was identified in 17/43 (39.5%) of cHL samples. This was higher in NLPHL (57.2%). In contrast, assessment of the relationship between clonal IGH D-J rearrangements and variation in density of cell surface antigens showed a significant difference in positive CD2 and CD3 cells as well as LCA (p < 0.005). It is worth mentioning that no statically significant difference was seen between positive CD30 cell population and IGH D-J rearrangements. A monoclonality of 8 -22% in IGH D-J, which was declared not to be applicable to cHL assessments, was reported previously [9, 14] . However, the present study reports a monoclonality, which is significantly higher than that of previous research (57.2% v 8% -22%). Furthermore, we analyzed a significant difference between positive CD30 cells and the rate of IGH monoclonality rearrangements. In agreement with previous research [11, 14, 15] , we found increases as the number of the positive CD30 population cells and the rate of monoclonality rearrangements were enhanced. Thus, it is conceivable that one of the most important differences of positive clonality is detected in association with the density of cancerous cells. However, further studies are needed to clarify these differences. In spite of the fact that different approaches (Gene Scanning and Heteroduplex gel electrophoresis) have been used to detect such rearrangements, these approaches have similar sensitivities in clonality PCR assays [10] . In addition, the relatively high percentage of clonality in the present study, compared to preceding research, may be a result of the relatively greater amounts of the DNA samples and high density of neoplastic CD30 positive cells.
CONCLUSION
The present study suggests that the rate of clonal gene rearrangements in HL was less than reported in NHL and the rate of positive monoclonality was closely related to the density of HRS. In conclusion, assessments of clonal gene rearrangements in IGH and IGH D-J using BIOMED-2 protocols could be considered as a valuable method to increase sensitivity and accuracy of determining HL, similarly to NHL.
